Glura M 50mg/1000mg: A Combined Therapy for Type 2 Diabetes Management

Glura M 50mg/1000mg tablets are a convenient and effective medication combination for managing Type 2 diabetes. This tablet combines sitagliptin (50mg) and metformin (1000mg), two key components in the treatment of blood sugar control.

Sitagliptin: This dipeptidyl peptidase-4 inhibitor works by increasing insulin release from beta cells, and helps lower fasting glucose levels in patients with Type 2 diabetes.
Metformin: A first-line antidiabetic medication, metformin helps improve insulin sensitivity, reducing the amount of glucose produced by the liver, and improving blood sugar control.

Glura M tablets provide a comprehensive approach to managing Type 2 Diabetes, targeting both insulin secretion and glucose production for optimal blood sugar management. Consult with your healthcare professional before use.

Important: This information is provided for general knowledge only and should not be considered medical advice. Always consult your doctor or pharmacist before taking any medication.